… that were discussed at this year’s event. mGluR5 to treat dyskinesia Charlotte Keywood , MBBS MRCP FFPM, of Addex … gold standard Parkinson’s drug which can sometimes lead to dyskinesia. The hope is that dipraglurant, which targets the …

… two broad categories: targets for therapies to alleviate dyskinesias, the excessive, uncontrollable movements brought … (mGluR5) could prevent the development of levodopa-induced dyskinesias. The current award will allow her to take this …

… Receptor Agonists for the Treatment of L-DOPA-induced Dyskinesia Manolo Carta, PhD, Lund University, Sweden   …   Effects of KCNQ (Kv7) Channel Openers in Levodopa-induced Dyskinesias Angelika Richter, PhD, Freie Universität Berlin, …

… critical step toward the development of new treatments for dyskinesia, the excessive and uncontrollable movements that … The goal is to establish a framework for testing novel anti-dyskinesia treatments by validating clinical scales used to …

… a drug currently used to treat high cholesterol, to reduce dyskinesias — the disruptive, uncontrollable movements that … trial of Simvastatin on the Treatment of Levodopa-induced Dyskinesia in Parkinson’s Disease Patients Erwan Bezard, …

… more and find a study center near you.   Seeking to Reduce Dyskinesia : Many people with PD take levodopa to manage … Long-term levodopa use could cause people to develop dyskinesia — uncontrolled movements. The SHINE study is …